S R Johnson

Summary

Affiliation: University of Iowa
Country: USA

Publications

  1. ncbi Defining benefits and risks for SERMs in clinical trials and clinical practice
    S R Johnson
    University of Iowa Colleges of Medicine and Public Health, Iowa City 52242, USA
    Ann N Y Acad Sci 949:304-14. 2001
  2. ncbi Uterine and vaginal effects of unopposed ultralow-dose transdermal estradiol
    Susan R Johnson
    Department of Obstetrics and Gynecology, Roy J and Lucille A Carver College of Medicine, University of Iowa, Iowa City 52242, USA
    Obstet Gynecol 105:779-87. 2005
  3. ncbi The Women's Health Initiative and hormone therapy, 5 years later
    Susan R Johnson
    University of Iowa, Iowa City 52242, USA
    Cleve Clin J Med 74:755-6. 2007
  4. ncbi Job satisfaction and workplace characteristics of primary and specialty care physicians at a bimodal medical school
    G R Bergus
    Department of Family Medicine, University of Iowa College of Medicine, Iowa City 52242, USA
    Acad Med 76:1148-52. 2001
  5. ncbi Persistent HPV infection in postmenopausal age women
    E M Smith
    Department of Epidemiology, 2800 SB, College of Public Health, University of Iowa, Iowa City, IA 52242, USA
    Int J Gynaecol Obstet 87:131-7. 2004
  6. ncbi Menopausal symptoms and treatment-related effects of estrogen and progestin in the Women's Health Initiative
    Vanessa M Barnabei
    Department of Obstetrics and Gynecology, Medical College of Wisconsin, 9200 West Wisconsin Avenue, Milwaukee, WI 53226, USA
    Obstet Gynecol 105:1063-73. 2005
  7. ncbi Hormone replacement therapy: applying the results of the Women's Health Initiative
    Susan R Johnson
    Cleve Clin J Med 69:682, 685. 2002
  8. ncbi The Women's Health Initiative postmenopausal hormone trials: overview and baseline characteristics of participants
    Marcia L Stefanick
    Stanford Center for Research in Disease Prevention, Stanford University, Palo Alto, CA, USA
    Ann Epidemiol 13:S78-86. 2003
  9. ncbi Incidence of cervical cytological abnormalities with aging in the women's health initiative: a randomized controlled trial
    Shagufta Yasmeen
    Department of Obstetrics Gynecology and Internal Medicine, University of California, Davis, 95817, USA
    Obstet Gynecol 108:410-9. 2006

Collaborators

Detail Information

Publications9

  1. ncbi Defining benefits and risks for SERMs in clinical trials and clinical practice
    S R Johnson
    University of Iowa Colleges of Medicine and Public Health, Iowa City 52242, USA
    Ann N Y Acad Sci 949:304-14. 2001
    ..In the practice setting, we elaborate the challenges of keeping up with the scientific literature and of then communicating this information in a fashion that is relevant to the individual patient...
  2. ncbi Uterine and vaginal effects of unopposed ultralow-dose transdermal estradiol
    Susan R Johnson
    Department of Obstetrics and Gynecology, Roy J and Lucille A Carver College of Medicine, University of Iowa, Iowa City 52242, USA
    Obstet Gynecol 105:779-87. 2005
    ..To investigate uterine effects of unopposed ultralow-dose transdermal estradiol administered to postmenopausal women for 2 years...
  3. ncbi The Women's Health Initiative and hormone therapy, 5 years later
    Susan R Johnson
    University of Iowa, Iowa City 52242, USA
    Cleve Clin J Med 74:755-6. 2007
  4. ncbi Job satisfaction and workplace characteristics of primary and specialty care physicians at a bimodal medical school
    G R Bergus
    Department of Family Medicine, University of Iowa College of Medicine, Iowa City 52242, USA
    Acad Med 76:1148-52. 2001
    ..A few medical schools are highly successful in obtaining research funding and producing primary care physicians. The authors compared the job satisfaction of primary and specialty care faculty at one of these bimodal schools...
  5. ncbi Persistent HPV infection in postmenopausal age women
    E M Smith
    Department of Epidemiology, 2800 SB, College of Public Health, University of Iowa, Iowa City, IA 52242, USA
    Int J Gynaecol Obstet 87:131-7. 2004
    ..Because this association in older, postmenopausal age women has received little attention, we evaluated persistence of HPV among women in this age group...
  6. ncbi Menopausal symptoms and treatment-related effects of estrogen and progestin in the Women's Health Initiative
    Vanessa M Barnabei
    Department of Obstetrics and Gynecology, Medical College of Wisconsin, 9200 West Wisconsin Avenue, Milwaukee, WI 53226, USA
    Obstet Gynecol 105:1063-73. 2005
    ..To estimate the effects of estrogen plus progestin (E+P) therapy on menopausal symptoms, vaginal bleeding, gynecologic surgery rates, and treatment-related adverse effects in postmenopausal women...
  7. ncbi Hormone replacement therapy: applying the results of the Women's Health Initiative
    Susan R Johnson
    Cleve Clin J Med 69:682, 685. 2002
  8. ncbi The Women's Health Initiative postmenopausal hormone trials: overview and baseline characteristics of participants
    Marcia L Stefanick
    Stanford Center for Research in Disease Prevention, Stanford University, Palo Alto, CA, USA
    Ann Epidemiol 13:S78-86. 2003
  9. ncbi Incidence of cervical cytological abnormalities with aging in the women's health initiative: a randomized controlled trial
    Shagufta Yasmeen
    Department of Obstetrics Gynecology and Internal Medicine, University of California, Davis, 95817, USA
    Obstet Gynecol 108:410-9. 2006
    ..To estimate the incidence of cytological abnormalities and cervical cancer and to determine the effect of oral estrogen and progestin on cervical cytology among postmenopausal women participating in a multi-institution clinical trial...